Olmesartan Medoxomilo Aurobindo

Olmesartan Medoxomil, the active ingredient in Olmesartan Medoxomilo Aurobindo, is an angiotensin II receptor blocker presented as a tablet for oral use. It is employed in the management of hypertension in adult patients. GNH USA supplies Olmesartan Medoxomilo Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmesartan Medoxomilo Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olmesartan Medoxomil is used to treat high blood pressure by targeting the renin‑angiotensin system.

- Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Heart failure: used as part of combination therapy to improve cardiac output and symptoms. - Diabetic nephropathy: helps slow progression of kidney damage associated with diabetes. - Post‑myocardial infarction: aids in blood‑pressure control after a heart attack. - Stroke prevention : assists in reducing the risk of recurrent stroke. - Chronic kidney disease : assists in managing blood‑pressure in patients with renal impairment.

Olmeset ​    .... ... ...  .... … .... … ...